How Can Saliva Diagnostics Help With Health Monitoring?
Photo credit: Pixabay
At the 96th General Session of the International Association for Dental Research (IADR), held in conjunction with the IADR Pan European Regional (PER) Congress, David Wong, University of California, Los Angeles, USA presented his research “Saliva Diagnostics and Salivaomics” as part of the symposium “Will Saliva Translate to a Real Diagnostic Tool?” on Saturday, July 28, 2018.
The IADR/PER General Session & Exhibition is in London, England at the ExCeL London Convention Center from July 25-28, 2018.
In the era of new diagnostic methods and treatment options, patient care is rapidly changing.
Early detection is an emerging paradigm which seeks to decrease patient morbidity and mortality by detecting disease at a phase where it is easily treatable.
Wong spoke about the exciting new opportunities to use saliva liquid biopsy for early assessment of lung cancer because of the clinical performance of cancer detection, non-invasive collection process and the ease of collecting, transporting and storing saliva.
Studies have been conducted using saliva to measure stress hormones, enzyme levels, developmental disease biomarkers and even cancer mutations.
If validated biomarkers were combined with high-quality detection tools, saliva would open up a new frontier in high-quality healthcare allowing physicians, dentists and patients to work together for real-time health monitoring and high-impact personalized preventative medicine.
“There are a variety of scenarios with which saliva can be used,” said Wong.
“One of the most exciting emerging frontiers of saliva is liquid biopsy, which is a non-invasive means to assess the presence and characteristics of cancer in a patient with an indeterminate pulmonary nodule detected by low dose computerized tomography (LDCT).”
Saliva liquid biopsy delivers the best performance in the detection of circulating tumor DNA of lung cancer.
This research was presented as part of the symposium “Will Saliva Translate to a Real Diagnostic Tool?” that took place on Saturday, July 28, 2018 from 8 a.m. – 9:30 a.m. at the ExCeL London Convention Center in London, England.
This article has been republished from materials provided by the International Association for Dental Research. Note: material may have been edited for length and content. For further information, please contact the cited source.
Patients in a new Northwestern Medicine study were able to comprehend words that were written but not said aloud. They could write the names of things they saw but not verbalize them. This provides an insight into the brain degeneration that defines the rare dementia termed primary progressive aphasia.